F. Chedevergne

Low Bone Mineral Density in Young Children with Cystic Fibrosis

Isabelle Sermet‐Gaudelus, J.-C. Souberbielle, Jean Charles Ruiz et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 102 citations

Medicine, Child Health, Pediatrics +16

Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription

Elise Dréano, Pierre‐Régis Burgel, Aurélie Hatton et al. · European Respiratory Journal · 2023 · 87 citations

Medicine, Pharmacology, Pharmacotherapy +14

Predictive factors for lumacaftor/ivacaftor clinical response

Alexandra Masson, Elena K. Schneider‐Futschik, Nesrine Baatallah et al. · Journal of Cystic Fibrosis · 2018 · 72 citations · Full text

Medicine, Internal Medicine, Clinical Decision Support +10

The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study

Pierre‐Régis Burgel, Isabelle Sermet‐Gaudelus, Emmanuelle Girodon et al. · The Lancet Respiratory Medicine · 2024 · 47 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Lumacaftor-ivacaftor effects on cystic fibrosis-related liver involvement in adolescents with homozygous F508 del-CFTR

David Drummond, Jérémy Dana, Laureline Berteloot et al. · Journal of Cystic Fibrosis · 2021 · 43 citations · Full text

Medicine, Molecular Medicine, Pediatrics +16